CD274 and lung cancer: The statistically significant factors between the lung cancer autoantibody false-negative group and the positive group were analyzed by binary logistic regression analysis and the probability of false-negative autoantibodies in patients with PD-L1 gene expression < 1% was 1.613 times higher than PD-L1 gene expression of 1-49%.